Archives
-
Angiotensin II Workflows for Vascular Research
2026-09-17
Build controlled hypertension, vascular remodeling, and aneurysm experiments with Angiotensin II as a defined receptor-level perturbation. This practical guide connects peptide handling to endothelial, smooth muscle, and in vivo readouts while translating a landmark Sp1/Sp3 study into actionable assay design.
-
RBMS1 Loss Rewires PD-L1 Control in TNBC
2026-09-17
The reference study identifies the RNA-binding protein RBMS1 as a regulator of immune-cold triple-negative breast cancer through a post-transcriptional RBMS1–B4GALT1–PD-L1 axis. Its findings suggest that RBMS1 depletion can reduce PD-L1 stability and improve responses to checkpoint-based or cellular immunotherapy, while also defining important limits for translating this mechanism into other signaling systems.
-
Transdermal PTEN mRNA for Melanoma Immunotherapy
2026-09-16
The reference study develops hyaluronate-conjugated lipid nanoparticles containing HA-DMG for topical delivery of PTEN mRNA into melanoma. Its findings connect localized transdermal delivery with PTEN restoration, immunogenic cell death, tumor suppression, and enhanced antitumor immune activity in a preclinical model.
-
Gallein for GPCR Signaling Research
2026-09-16
Gallein is a practical G protein βγ subunit inhibitor for testing how GPCR-linked signals shape cancer invasion, immune-cell state, cardiac remodeling, and metabolic responses. This workflow-centered guide connects validated disease-model applications with the lactate–GPR81/FARP1 glucose-uptake pathway and shows how to build interpretable pharmacology experiments.
-
Metformin, EDH, and Mesenteric Vasorelaxation in Colitis
2026-09-15
This 2025 study identifies endothelium-dependent hyperpolarization as a central mechanism of metformin-induced relaxation in intestinal resistance vessels and links that response to protection of colitis-damaged mucosa. Its combination of wire myography, endothelial calcium and electrophysiology experiments, TRPV4 genetics, and a DSS colitis model provides a mechanistic framework for studying vascular contributions to intestinal inflammation.
-
Biotin-16-UTP for RNA Labeling Workflows
2026-09-15
Biotin-16-UTP enables affinity-ready RNA for detection, purification, localization, and RNA–protein studies without genetically modifying the target protein. This practical guide connects controlled in vitro transcription RNA labeling with assay design lessons from a recent endogenous-protein biosensor study.
-
Carbapenemase Transmission in Enterobacter cloacae
2026-09-14
A 2025 BMC Microbiology study mapped carbapenemase-encoding genes, mobile elements, and strain relatedness among carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong. Its findings connect plasmid-associated blaNDM-1 with multidrug resistance and efficient conjugative transfer, while ERIC-PCR indicates concurrent clonal dissemination across clinical settings.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase
2026-09-14
CAY10499 enables controlled interrogation of HSL, MGL, and FAAH activity in biochemical, lipid-flux, and macrophage immunometabolism workflows. Its value in extracellular vesicle-driven tumor studies is complementary to ACLY inhibition: it tests downstream lipid handling without being presented as a direct ACLY inhibitor.
-
Munc18c–Syntaxin4 Control of Tumor Cell Invasion
2026-09-13
The reference study identifies Munc18c as a functional regulator of syntaxin4 during invadopodium formation, linking SNARE control to the trafficking of MT1-MMP and EGFR. Its peptide-competition and loss-of-function experiments show how disrupting the Munc18c–syntaxin4 axis reduces extracellular matrix invasion in tumor cells.
-
PARP1–FAK–COL5A1 Signaling in Ovarian Cancer
2026-09-12
The reference study establishes a cholesterol-resistant ovarian cancer model and identifies a PARP1–FAK/Src–COL5A1 axis that promotes epithelial–mesenchymal transition and tumorigenesis. Its design links chronic metabolic stress to adhesion-associated signaling, providing a mechanistic framework for cancer biology research and pathway-focused intervention studies.
-
Citrate Molarity Shapes mRNA-LNP Function
2026-09-11
The reference study shows that citrate buffer molarity can alter mRNA-LNP internalization and transfection even when conventional measurements such as average particle size, polydispersity, and encapsulation efficiency appear comparable. Its findings support treating buffer composition as a critical process variable and pairing routine quality attributes with morphology, uptake, potency, and in vivo expression analyses.
-
GW 6471: Causal PPARα Assay Design
2026-09-11
GW 6471 is a mechanistically defined PPARα antagonist for separating pathway association from causality. This article translates PFHxS zebrafish evidence into rigorous assay-design decisions for cellular metabolism research, lipid homeostasis studies, and related disease models.
-
CTP Solution (100 mM) for RNA Synthesis
2026-09-10
CTP Solution is an aqueous Cytidine-5'-triphosphate reagent for RNA synthesis, in vitro transcription, and related biochemical workflows. The K1045 formulation provides ≥99% HPLC-purity CTP at 100 mM and is designed for sensitive reactions that require controlled pH and low nuclease or phosphatase contamination.
-
Alternariol Drives LX-2 Fibrotic Reprogramming
2026-09-10
The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can convert LX-2 hepatic stellate cells toward a contractile, extracellular-matrix-producing myofibroblast phenotype, whereas tenuazonic acid showed no significant effect in the tested model. By integrating lncRNA–mRNA omics with pathway analysis and a CotA laccase detoxification strategy, the work connects emerging Alternaria toxins with hepatic fibrotic signaling.
-
EDC.HCl Coupling Workflow Guide
2026-09-09
EDC.HCl is a water-soluble carbodiimide for activating carboxyl groups before amide bond formation with primary amines in controlled laboratory workflows. It is suitable for in vitro peptide synthesis, bioconjugation, and related coupling applications, but no in vivo or clinical data are available for this reagent.